Hosted on MSN23h
Guggenheim Downgrades ACADIA Pharmaceuticals (ACAD)Fintel reports that on January 3, 2025, Guggenheim downgraded their outlook for ACADIA Pharmaceuticals (NasdaqGS:ACAD) from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback